You just read:

NextSource Biotechnology Announces FDA Short Supply release of the formally known Bristol Myers Squibb (CeeNu®) Brand Oncology product now currently marketed under the NextSource Biotechnology Lomustine (CCNU) label Exclusively in the United States

News provided by

NextSource BioTechnology, LLC

Jan 24, 2014, 02:51 EST